| Title |
Insight into Acinetobacter baumannii: pathogenesis, global resistance, mechanisms of resistance, treatment options, and alternative modalities
|
|---|---|
| Published in |
Infection and Drug Resistance, August 2018
|
| DOI | 10.2147/idr.s166750 |
| Pubmed ID | |
| Authors |
Muhammad Asif, Iqbal Ahmad Alvi, Shafiq Ur Rehman |
| Abstract |
Acinetobacter baumannii, once considered a low-category pathogen, has emerged as an obstinate infectious agent. The scientific community is paying more attention to this pathogen due to its stubbornness to last resort antimicrobials, including carbapenems, colistin, and tigecycline, its high prevalence of infections in the hospital setting, and significantly increased rate of community-acquired infections by this organism over the past decade. It has given the fear of pre-antibiotic era to the world. To further enhance our understanding about this pathogen, in this review, we discuss its taxonomy, pathogenesis, current treatment options, global resistance rates, mechanisms of its resistance against various groups of antimicrobials, and future therapeutics. |
X Demographics
The data shown below were collected from the profiles of 13 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Spain | 4 | 31% |
| Pakistan | 1 | 8% |
| Venezuela, Bolivarian Republic of | 1 | 8% |
| Mexico | 1 | 8% |
| Niger | 1 | 8% |
| Malaysia | 1 | 8% |
| Unknown | 4 | 31% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 11 | 85% |
| Practitioners (doctors, other healthcare professionals) | 2 | 15% |
Mendeley readers
The data shown below were compiled from readership statistics for 567 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 567 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Bachelor | 96 | 17% |
| Student > Master | 81 | 14% |
| Student > Ph. D. Student | 51 | 9% |
| Student > Postgraduate | 40 | 7% |
| Researcher | 33 | 6% |
| Other | 67 | 12% |
| Unknown | 199 | 35% |
| Readers by discipline | Count | As % |
|---|---|---|
| Biochemistry, Genetics and Molecular Biology | 101 | 18% |
| Immunology and Microbiology | 78 | 14% |
| Medicine and Dentistry | 67 | 12% |
| Agricultural and Biological Sciences | 41 | 7% |
| Pharmacology, Toxicology and Pharmaceutical Science | 14 | 2% |
| Other | 57 | 10% |
| Unknown | 209 | 37% |
Attention Score in Context
This research output has an Altmetric Attention Score of 13. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 23 October 2022.
All research outputs
#2,749,570
of 24,701,594 outputs
Outputs from Infection and Drug Resistance
#104
of 1,975 outputs
Outputs of similar age
#54,468
of 335,829 outputs
Outputs of similar age from Infection and Drug Resistance
#6
of 57 outputs
Altmetric has tracked 24,701,594 research outputs across all sources so far. Compared to these this one has done well and is in the 88th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,975 research outputs from this source. They receive a mean Attention Score of 4.6. This one has done particularly well, scoring higher than 94% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 335,829 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 83% of its contemporaries.
We're also able to compare this research output to 57 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 91% of its contemporaries.